35.60BMarket Cap18.12P/E (TTM)
582.820High577.520Low221.79KVolume580.000Open580.140Pre Close128.79MTurnover0.37%Turnover Ratio30.95P/E (Static)61.12MShares624.92852wk High3.88P/B35.33BFloat Cap448.81552wk Low3.01Dividend TTM60.65MShs Float624.928Historical High0.52%Div YieldTTM0.91%Amplitude16.174Historical Low580.708Avg Price1Lot Size
Martin Marietta Materials Stock Forum
U.S. equities ended the trading day with mixed results, reflecting cautious investor sentiment amid ongoing tech stock rotation and the anticipation of potential interest rate cuts by the Federal Reserve. $Dow Jones Industrial Average (.DJI.US)$ closed at a new record high of 41,250.50, up 0.02% (or 9 points). Meanwhile, both the $S&P 500 Index (.SPX.US)$ and $Nasdaq Composite Index (.IXIC.US)$ gained 0.2%.
Key Stock M...
These names also hit fresh highs:
$Royal Caribbean (RCL.US)$ trading at levels not seen since Feb, 2021
$McCormick & Co (MKC.US)$ trading at levels not seen s...
• $Advanced Micro Devices (AMD.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $115 (from $100)
• $Amphenol (APH.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $83
• $CDW Corp (CDW.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $200 (from $205)
• $Costco (COST.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $579 (from $525)
• $New Oriental (EDU.US)$ : CICC Upgrades to Outperform from M...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet